Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2005-03-21
2009-10-13
Liu, Sue (Department: 1639)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C436S085000, C436S518000, C530S350000
Reexamination Certificate
active
07601510
ABSTRACT:
A method for high throughput screening of probes is described. These probes are useful for characterization and measurement of unbound metabolites in a fluid sample, particularly characterization and measurement of levels of unbound free fatty acids. By practice of the disclosed invention, a profile of unbound metabolites can be determined for an individual which can be used to determine the individual's relative risk for disease such as stroke, cardiac disease and cancer.
REFERENCES:
patent: 4071413 (1978-01-01), Takahashi et al.
patent: 4369250 (1983-01-01), Gindler
patent: 4491631 (1985-01-01), Imamura et al.
patent: 4580059 (1986-04-01), Wolfbeis et al.
patent: 4833332 (1989-05-01), Robertson et al.
patent: 5225329 (1993-07-01), Marks
patent: 5227307 (1993-07-01), Bar-Or et al.
patent: 5449607 (1995-09-01), Wilton
patent: 5470714 (1995-11-01), Kleinfeld
patent: 5496735 (1996-03-01), Schwertner
patent: 5512429 (1996-04-01), Wilton
patent: 5604105 (1997-02-01), Jackowski
patent: 5914112 (1999-06-01), Bednar et al.
patent: 5914245 (1999-06-01), Bylina et al.
patent: 5977174 (1999-11-01), Bradley et al.
patent: 6210976 (2001-04-01), Sabbadini
patent: 6264960 (2001-07-01), Robins et al.
patent: 6344316 (2002-02-01), Lockhart et al.
patent: 6444432 (2002-09-01), Kleinfeld
patent: 6461875 (2002-10-01), Bar-Or et al.
patent: 6475743 (2002-11-01), Bar-Or et al.
patent: 6492179 (2002-12-01), Bar-Or et al.
patent: 6563585 (2003-05-01), Rao et al.
patent: 6727258 (2004-04-01), Baraldi
patent: 6750030 (2004-06-01), Kleinfeld
patent: 7202089 (2007-04-01), Kleinfeld et al.
patent: 2002/0013003 (2002-01-01), Wagner et al.
patent: 2002/0081617 (2002-06-01), Buranda et al.
patent: 2002/0142347 (2002-10-01), Knudsen et al.
patent: 2002/0168692 (2002-11-01), Cass
patent: 2002/0182197 (2002-12-01), Black et al.
patent: 2004/0019109 (2004-01-01), Owman et al.
patent: 2004/0077017 (2004-04-01), Karlstrom et al.
patent: 2005/0239155 (2005-10-01), Alarcon et al.
patent: 2005/0244864 (2005-11-01), Kleinfeld et al.
patent: 2006/0257938 (2006-11-01), Kleinfeld et al.
patent: 1 043 587 (2003-06-01), None
patent: 1270706 (1981-09-01), None
patent: WO 91/09310 (1991-06-01), None
patent: WO 93/08276 (1993-04-01), None
patent: WO 94/06014 (1994-03-01), None
patent: WO 98/57171 (1998-12-01), None
patent: WO 00/20840 (2000-04-01), None
patent: WO 00/47734 (2000-08-01), None
patent: WO 00/74728 (2000-12-01), None
patent: WO 02/089656 (2002-11-01), None
patent: WO 03/093438 (2003-11-01), None
patent: WO 2005/093103 (2005-10-01), None
Definition for “Absolute Value”; Merriam-Webster Online Dictionary; downloaded from Merriam-webseter.com; downloaded on Mar. 25, 2008.
Lamla et al., Journal of Molecular Biology. vol. 329: 381-388; published online May 13, 2003.
Richieri et al., Journal of Biological Chemistry. vol. 272 (27): 16737-16740; 1997.
Supplementary Partial European Search Report completed on Dec. 21, 2004 and issued to a related, foreign application.
International Search Report completed Nov. 11, 2002 and issued to a related, foreign application.
Bansal, et al. “Stroke During Pregnancy and Puerperium in Young Females Below the Age of 40 Years as a Result of Cerebral Venous/Venous Sinus Thrombosis,”Japanese Heart Journal, vol. 21, No. 2, pp. 171-183, Mar. 1980.
Ageeva et al. “Structural and Functional Characteristics of Red Cell Membranes in Patients with Ischemic Stroke and Dyscirculatory Encephalopathy,” Zhurnal Nevrollogii I Psikhiatrii Imeni SS Korsakova, vol. 94, No. 1, pp. 6-8, 1994. English Abstract.
Imre, et al. “Increased proportion of Docosahexanoic Acid and High Lipid Peroxidation Capacity in Erythrocytes of Stroke Patients,”Stroke, vol. 25, No. 12, pp. 2416-2420 1994.
Supplementary European Search Report completed on Aug. 12, 2004 and issued to a related foreign application.
International Search Report dated Feb. 20, 2003, from a related foreign application (PCT/US02/2947).
Brown, et al. “Fatty Acids and the Inhibition of Mitogen-Induced Lymphocyte Transformation by Leukemic Serum,”The Journal of Immunology, vol. 131, No. 2, pp. 1011-1016, Aug. 1983.
Butko, et al. “Acidic Phospholipids Strikingly Potentiate Sterol Carrier Protein 2 Mediated Intermembrane Sterol Transfer,”Biochemistry, vol. 29, pp. 4070-4077, 1990.
Bazan, et al. “Membrane Lipids in the Pathogenesis of Brain Edema: Phospholipids and Arachidonic Acid, the Earliest membrane Components Changed at the Onset of Ischemia,”Advances in Neurology, vol. 28: Brain Edema, Raven Press, New York, 1980, pp. 197-204.
Bazan, et al. “Effects of lschemia and Electroconvulsive Shock on Free Fatty Acid Pool in the Brain,”Biochimica et Biophysica Acta, 218, 1970, pp. 1-10.
Ikeda, et al. “Polyphosphoinositides as a Probable Source of Brain Free Fatty Acids Accumulated at the Onset of Ischemia,”Journal of Neurochemistry, Vo. 47(1), pp. 123-132, 1986.
Kurien, “Serum-Free-Fatty-Acids After Acute Myocardial Infarction and Cerebral Vascular Occlusion,”The Lancet, Jul. 16, 1966, pp. 122-127.
Richieri, et al. “Unbound Free Fatty Acid Levels in Human Serum,”Journal of Lipid Research, vol. 36, 1995, pp. 229-240.
Richieri, et al. “Interactions of Long-Chain Fatty Acids and Albumin: Determination of free Fatty Acid Levels Using the Fluorescent Probe ADIFAB,”Biochemistry, vol. 2, 1993, pp. 7574-7580.
Richieri, et al. “Kinetics of Fatty Acid Interactions with Fatty Acid Binding Proteins from Adipocyte, Heart, and Intestine,”The Journal of Biological Chemistry, vol. 271, No. 19, May 10, 1996, pp. 11291-11300.
Richieri, et al. “The Measurement of Free Fatty Acid Concentration with the Fluorescent Probe ADIFAB: A Practical Guide for the Use of the ADIFAB Probe,”Molecular and Cellular Biochemistry, 192: 1999, pp. 87-94.
Richieri, et al. “A Fluorescently Labeled Intestinal Fatty Acid Binding Protein,”The Journal of Biological Chemistry, vol. 267, No. 33, Nov. 25, 1992, pp. 23495-23501.
Richieri, et al. “Equilibrium Constants for the Binding of Fatty Acids with Fatty Acid-Binding Proteins from Adipocyte, Intestine, Heart, and Liver Measured with the Fluorescent Probe ADIFAB,”The Journal of Biological Chemistry, vol. 269, No. 39, pp. 23918-23930, 1994.
Weinberger, et al. “Effects of Perinatal Hypoxia on Serum Unbound Free Fatty Acids and Lung Inflammatory Mediators,”Biology of the Neonate, vol. 79, 2001, pp. 61066.
Ruben, et al. “Serum Level of Unbound Free Fatty Acids II: The Effect of Intralipid Administration in Premature Infants,”Journal of American College of Nutrition, vol. 16, No. 1, pp. 85-87, 1997.
Patel et al. “Serum Levels of Unbound Free Fatty Acids I: Normative Data in Term Newborn Infants,”Journal of American College of Nutrition, vol. 16, No. 1, pp. 81-84, 1997.
Kleinfeld, et al. “Increases in Serum Unbound Free Fatty Acid Levels Following Coronary Angioplasty”,American Journal of Cardiology, vol. 78, No. 12, pp. 1350-1354, Dec. 15, 1996 (abstract).
Ford, et al. “Use of Serum Markers of Myocardial Injury for the Early Diagnosis of Acute Myocardial Infarction,”Acc Current Journal Review, pp. 86-89, May/Jun. 1996.
Stedman's Medical Dictionary, 27thEdition, Lippincott Williams & Wilkins, editors, p. 924.
White, Chapter 16, “Unstable Angina, Ischemic Syndromes,”Textbook of Cardiovascular Medicine, edited by Eric J. Topol, Lippincott Williams & Wilkins, editors, Philadelphia, 1998, pp. 365-393.
Peuhkurinen, et al. “Changes in Myocardial Energy Metabolism in Elective Coronary Angioplasty,”Cardiovascular Research, vol. 25, pp. 158-163, 1991.
Victor, et al. “Myocardial Tissue Free Fatty Acids,”Journal of Molecular and Cellular Cardiology, vol. 16, No. 8, pp. 709-721, Aug. 1984.
Samanta, et al. “Possible Physiological Role of Myocardial Fatty Acid Binding Protein in Phospholipid Biosynthesis,”Journal of Lipid
Huber Andrew Henry
Kampf James Patrick
Kleinfeld Alan Marc
Kwan Thomas
Zhu Baolong
FFA Sciences LLC
Knobbe Martens Olson & Bear LLP
Liu Sue
LandOfFree
Development and use of fluorescent probes of unbound analytes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Development and use of fluorescent probes of unbound analytes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Development and use of fluorescent probes of unbound analytes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4122577